Literature DB >> 30278128

FINDSITEcomb2.0: A New Approach for Virtual Ligand Screening of Proteins and Virtual Target Screening of Biomolecules.

Hongyi Zhou1, Hongnan Cao1, Jeffrey Skolnick1.   

Abstract

Computational approaches for predicting protein-ligand interactions can facilitate drug lead discovery and drug target determination. We have previously developed a threading/structural-based approach, FINDSITEcomb, for the virtual ligand screening of proteins that has been extensively experimentally validated. Even when low resolution predicted protein structures are employed, FINDSITEcomb has the advantage of being faster and more accurate than traditional high-resolution structure-based docking methods. It also overcomes the limitations of traditional QSAR methods that require a known set of seed ligands that bind to the given protein target. Here, we further improve FINDSITEcomb by enhancing its template ligand selection from the PDB/DrugBank/ChEMBL libraries of known protein-ligand interactions by (1) parsing the template proteins and their corresponding binding ligands in the DrugBank and ChEMBL libraries into domains so that the ligands with falsely matched domains to the targets will not be selected as template ligands; (2) applying various thresholds to filter out falsely matched template structures in the structure comparison process and thus their corresponding ligands for template ligand selection. With a sequence identity cutoff of 30% of target to templates and modeled target structures, FINDSITEcomb2.0 is shown to significantly improve upon FINDSITEcomb on the DUD-E benchmark set by increasing the 1% enrichment factor from 16.7 to 22.1, with a p-value of 4.3 × 10-3 by the Student t-test. With an 80% sequence identity cutoff of target to templates for the DUD-E set and modeled target structures, FINDSITEcomb2.0, having a 1% ROC enrichment factor of 52.39, also outperforms state-of-the-art methods that employ machine learning such as a deep convolutional neural network, CNN, with an enrichment of 29.65. Thus, FINDSITEcomb2.0 represents a significant improvement in the state-of-the-art. The FINDSITEcomb2.0 web service is freely available for academic users at http://pwp.gatech.edu/cssb/FINDSITE-COMB-2 .

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30278128      PMCID: PMC6437778          DOI: 10.1021/acs.jcim.8b00309

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  50 in total

1.  Ligand-protein inverse docking and its potential use in the computer search of protein targets of a small molecule.

Authors:  Y Z Chen; D G Zhi
Journal:  Proteins       Date:  2001-05-01

2.  Benchmarking sets for molecular docking.

Authors:  Niu Huang; Brian K Shoichet; John J Irwin
Journal:  J Med Chem       Date:  2006-11-16       Impact factor: 7.446

Review 3.  Repurposing libraries of eukaryotic protein kinase inhibitors for antibiotic discovery.

Authors:  Christopher T Walsh; Michael A Fischbach
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-04       Impact factor: 11.205

Review 4.  Impact of high-throughput screening in biomedical research.

Authors:  Ricardo Macarron; Martyn N Banks; Dejan Bojanic; David J Burns; Dragan A Cirovic; Tina Garyantes; Darren V S Green; Robert P Hertzberg; William P Janzen; Jeff W Paslay; Ulrich Schopfer; G Sitta Sittampalam
Journal:  Nat Rev Drug Discov       Date:  2011-03       Impact factor: 84.694

5.  The Protein Data Bank: a computer-based archival file for macromolecular structures.

Authors:  F C Bernstein; T F Koetzle; G J Williams; E F Meyer; M D Brice; J R Rodgers; O Kennard; T Shimanouchi; M Tasumi
Journal:  J Mol Biol       Date:  1977-05-25       Impact factor: 5.469

6.  Q-Dock: Low-resolution flexible ligand docking with pocket-specific threading restraints.

Authors:  Michal Brylinski; Jeffrey Skolnick
Journal:  J Comput Chem       Date:  2008-07-30       Impact factor: 3.376

7.  Q-Dock(LHM): Low-resolution refinement for ligand comparative modeling.

Authors:  Michal Brylinski; Jeffrey Skolnick
Journal:  J Comput Chem       Date:  2010-04-15       Impact factor: 3.376

8.  The Pfam protein families database.

Authors:  Alex Bateman; Ewan Birney; Lorenzo Cerruti; Richard Durbin; Laurence Etwiller; Sean R Eddy; Sam Griffiths-Jones; Kevin L Howe; Mhairi Marshall; Erik L L Sonnhammer
Journal:  Nucleic Acids Res       Date:  2002-01-01       Impact factor: 16.971

9.  Large-scale prediction and testing of drug activity on side-effect targets.

Authors:  Eugen Lounkine; Michael J Keiser; Steven Whitebread; Dmitri Mikhailov; Jacques Hamon; Jeremy L Jenkins; Paul Lavan; Eckhard Weber; Allison K Doak; Serge Côté; Brian K Shoichet; Laszlo Urban
Journal:  Nature       Date:  2012-06-10       Impact factor: 49.962

10.  Predicting drug-target interactions using probabilistic matrix factorization.

Authors:  Murat Can Cobanoglu; Chang Liu; Feizhuo Hu; Zoltán N Oltvai; Ivet Bahar
Journal:  J Chem Inf Model       Date:  2013-12-10       Impact factor: 4.956

View more
  11 in total

1.  Stalis: A Computational Method for Template-Based Ab Initio Ligand Design.

Authors:  Hui Sun Lee; Wonpil Im
Journal:  J Comput Chem       Date:  2019-03-04       Impact factor: 3.376

2.  Implications of the Essential Role of Small Molecule Ligand Binding Pockets in Protein-Protein Interactions.

Authors:  Jeffrey Skolnick; Hongyi Zhou
Journal:  J Phys Chem B       Date:  2022-08-31       Impact factor: 3.466

3.  Gene Interaction Network Analysis Reveals IFI44L as a Drug Target in Rheumatoid Arthritis and Periodontitis.

Authors:  Pradeep Kumar Yadalam; Thilagar Sivasankari; Santhiya Rengaraj; Maryam H Mugri; Mohammed Sayed; Samar Saeed Khan; Mona Awad Kamil; Shilpa Bhandi; A Thirumal Raj; Shankargouda Patil; Artak Heboyan
Journal:  Molecules       Date:  2022-04-25       Impact factor: 4.927

4.  Gene and protein interaction network analysis in the epithelial-mesenchymal transition of Hertwig's Epithelial Root Sheath reveals periodontal regenerative drug targets - An in silico study.

Authors:  Pradeep Kumar Yadalam; Indhu Krishnamurthi; R Srimathi; Khalid J Alzahrani; Maryam H Mugri; Mohammed Sayed; Khalid H Almadi; Mazen F Alkahtany; Mohammad Almagbol; Shilpa Bhandi; Hosam Ali Baeshen; A Thirumal Raj; Shankargouda Patil
Journal:  Saudi J Biol Sci       Date:  2022-03-10       Impact factor: 4.052

5.  Virtual Screening of Human Class-A GPCRs Using Ligand Profiles Built on Multiple Ligand-Receptor Interactions.

Authors:  Wallace K B Chan; Yang Zhang
Journal:  J Mol Biol       Date:  2020-07-09       Impact factor: 5.469

6.  Web-ARM: A Web-Based Interface for the Automatic Construction of QM/MM Models of Rhodopsins.

Authors:  Laura Pedraza-González; María Del Carmen Marín; Alejandro N Jorge; Tyler D Ruck; Xuchun Yang; Alessio Valentini; Massimo Olivucci; Luca De Vico
Journal:  J Chem Inf Model       Date:  2020-02-10       Impact factor: 4.956

7.  MEDICASCY: A Machine Learning Approach for Predicting Small-Molecule Drug Side Effects, Indications, Efficacy, and Modes of Action.

Authors:  Hongyi Zhou; Hongnan Cao; Lilya Matyunina; Madelyn Shelby; Lauren Cassels; John F McDonald; Jeffrey Skolnick
Journal:  Mol Pharm       Date:  2020-04-13       Impact factor: 4.939

8.  Differential kinase activity of ACVR1 G328V and R206H mutations with implications to possible TβRI cross-talk in diffuse intrinsic pontine glioma.

Authors:  Hongnan Cao; Miao Jin; Mu Gao; Hongyi Zhou; Yizhi Jane Tao; Jeffrey Skolnick
Journal:  Sci Rep       Date:  2020-04-09       Impact factor: 4.379

9.  FRAGSITE: A Fragment-Based Approach for Virtual Ligand Screening.

Authors:  Hongyi Zhou; Hongnan Cao; Jeffrey Skolnick
Journal:  J Chem Inf Model       Date:  2021-03-16       Impact factor: 4.956

10.  Antimalarial Peptide and Polyketide Natural Products from the Fijian Marine Cyanobacterium Moorea producens.

Authors:  Anne Marie Sweeney-Jones; Kerstin Gagaring; Jenya Antonova-Koch; Hongyi Zhou; Nazia Mojib; Katy Soapi; Jeffrey Skolnick; Case W McNamara; Julia Kubanek
Journal:  Mar Drugs       Date:  2020-03-18       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.